HealthWell Foundation Chemotherapy Induced Neutropenia - Medicare Access Fund
HealthWell Foundation
ClosedUnder review·Apr 24, 2026
This HealthWell Foundation grant assists Medicare patients with chemotherapy-induced neutropenia by covering prescription drug copays or Medicare Part B insurance premiums, up to a maximum of $3,500. Eligibility requires treatment in the U.S. and a household income up to 500% of the Federal Poverty Level, adjusted for household size and cost of living areas.
- Covers
- financial assistance
- Enrollment cycle
- as_funded
Apply
Application goes directly to HealthWell Foundation. RxCopays does not receive compensation.
Go to application →Status source
This fund is temporarily closed to new patients due to lack of sufficient funding.